Medical Market Report

Global Intravenous (IV) Solution Market By Type (by Product Type, Total Parenteral Solution, Peripheral Parenteral Solution, by Nutritional Content, Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion, and Others), By Application (Hospitals & Clinics, Ambulatory, and Homecare), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 139131
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Intravenous (IV) Solution Market is estimated to be valued US$ XX.X million in 2019. The report on Intravenous (IV) Solution Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global intravenous (iv) solution market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Intravenous (IV) Solution Market Scope:

    By type, the market is segmented into by Product Type, Total Parenteral Solution, Peripheral Parenteral Solution, by Nutritional Content, Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion, and Others. By Application, the market is divided into Hospitals & Clinics, Ambulatory, and Homecare.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include ICU Medical, B. Braun Melsungen, Fresenius Kabi, Baxter, Amanta Healthcare, Terumo Medical Corporation, and Grifols.

    Key Market Segments

    Type

    by Product Type

    Total Parenteral Solution

    Peripheral Parenteral Solution

    by Nutritional Content

    Amino Acid Solution

    Carbohydrates

    Vitamins & Minerals

    Parenteral Lipid Emulsion

    Others

    Application

    Hospitals & Clinics

    Ambulatory

    Homecare

    Key Market Players included in the report:

    ICU Medical

    B. Braun Melsungen

    Fresenius Kabi

    Baxter

    Amanta Healthcare

    Terumo Medical Corporation

    Grifols

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Intravenous (IV) Solution Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Intravenous (IV) Solution Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Intravenous (IV) Solution Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Intravenous (IV) Solution Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Intravenous (IV) Solution Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Intravenous (IV) Solution Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Intravenous (IV) Solution sub-markets, depending on key regions (various vital states).
    To analyze Intravenous (IV) Solution Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Intravenous (IV) Solution Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Intravenous (IV) Solution Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Intravenous (IV) Solution Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Intravenous (IV) Solution Market Overview
    

    3.1. Intravenous (IV) Solution Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Intravenous (IV) Solution Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Intravenous (IV) Solution Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. by Product Type
    

      4.4. Total Parenteral Solution
    

      4.5. Peripheral Parenteral Solution
    

      4.6. by Nutritional Content
    

      4.7. Amino Acid Solution
    

      4.8. Carbohydrates
    

      4.9. Vitamins & Minerals
    

      4.10. Parenteral Lipid Emulsion
    

      4.11. Others
    

    5. Global Intravenous (IV) Solution Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Intravenous (IV) Solution Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospitals & Clinics
    

      5.4. Ambulatory
    

      5.5. Homecare
    

    6. Global Intravenous (IV) Solution Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Intravenous (IV) Solution Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Intravenous (IV) Solution Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Intravenous (IV) Solution Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Intravenous (IV) Solution Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Intravenous (IV) Solution Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Intravenous (IV) Solution Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. ICU Medical
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. B. Braun Melsungen
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Fresenius Kabi
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Baxter
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Amanta Healthcare
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Terumo Medical Corporation
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Grifols
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.